Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lonza Adds High-Potency Capacity
10:06 AM MDT | June 28, 2007 | Chemical Week Editorial Staff
Lonza says it will build a plant at Visp, Switzerland to produce high-potency active pharmaceutical ingredients at large scale. The facility, which is due to cost SF80 million ($64 million), is scheduled to open in mid-2008. “The project provides Lonza with a unique competitive advantage by being the sole custom manufacturer capable of handling large-scale manufacturing in this arena,” Lonza...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee